GLP-1 Side Effects Month by Month: What to Expect on Semaglutide and Tirzepatide, and What Helps

the short answer

The common side effects of semaglutide and tirzepatide are digestive: nausea, early fullness, burping, constipation, and loose stools. They cluster in the first two to three months, mostly in the week after each dose increase, and most fade as the dose settles. A few symptoms need a same-day call to the physician.

Those few are severe or persistent abdominal pain, vomiting you cannot keep fluids down through, signs of dehydration, constipation that goes past a week with no relief, and any sign of an allergic reaction. Everything else on this page is the ordinary adjustment period, and there is a food, fluid, or timing step for each part of it.

This guide covers why the side effects happen, what months 1, 2 to 3, and 4 to 6 usually look like, what the long-term trial data covers, the symptoms that need a call, and how the physician manages dose steps at Pepvio. It applies to compounded semaglutide, the same molecule as Ozempic® and Wegovy®, and compounded tirzepatide, the same molecule as Mounjaro® and Zepbound®. The tirzepatide guide covers how the medication works and what results to expect.

why the side effects happen

Both medications copy GLP-1, a hormone your gut releases after a meal. It does two things that matter here. It signals the brain that you have eaten, so hunger drops and fullness arrives sooner. And it slows how fast the stomach empties, so food sits longer. Slower emptying is where most of the side effects come from: a stomach that is still holding breakfast when lunch arrives produces nausea, a heavy feeling, burping, and reflux. Slower transit through the gut produces constipation in some people and looser stools in others.

The dose is stepped up over the first months because the body adjusts to each level. Each increase raises the amount of medication in your blood, the stomach slows a little more, and it takes one to two weeks for that to settle. That is why side effects return briefly at each step and then ease again, and why they are most noticeable in the first two to three months, when the steps are happening.

The trial numbers match that pattern. On the semaglutide label, from the trials that led to its approval for weight, nausea was reported by 44 percent of people on the full dose against 16 percent on placebo, diarrhea by 30 percent against 16, and constipation by 24 percent against 11.^[4] In STEP 1, the main semaglutide trial, those events were typically transient, mild to moderate, and subsided with time; 4.5 percent of people on semaglutide stopped because of digestive side effects, against 0.8 percent on placebo.^[1] Tirzepatide's numbers run lower: nausea in 25 to 29 percent depending on dose, against 8 percent on placebo, and constipation in 11 to 17 percent against 5.^[5] In SURMOUNT-1, the main tirzepatide trial, most of those events were mild to moderate and occurred mainly during the 20-week dose-escalation period.^[2]

month 1: the starting dose

Weeks 1 to 4 are on the lowest dose. Appetite usually drops within the first week, and most people notice that they feel full on less food. The side effects in this stretch are mild nausea, especially an hour or two after eating, a fuller stomach than the meal warrants, burping, and either constipation or a few days of looser stools while the gut adjusts. Some people get none of these on the starting dose.

What helps in month 1:

• Smaller meals. The stomach is emptying more slowly, so a normal-sized meal now sits longer. Half portions, more often, produce far less nausea than three full plates.
• Stop when you feel full. Fullness arrives earlier than it used to. Eating past it is the most common cause of nausea in the first month.
• Protein first. Start each meal with the protein, then vegetables, then anything else. Protein keeps muscle while you lose weight and is the part of the plate you are most likely to skip once appetite drops.
• Skip greasy, fried, and very large meals. Fat slows stomach emptying on its own; combined with the medication it is the single most reliable way to feel sick.
• Water through the day. Dehydration makes nausea and constipation worse, and thirst signals are quieter when you are eating less. Keep a bottle nearby and sip it steadily.

On timing: the medication is a once-weekly injection, and the day after the shot is when the effect is strongest for most people. Many people inject in the evening or before a day when a light meal is easy to arrange, and keep meals smaller for the following day or two. A small, plain meal before the injection also helps.

months 2 and 3: the dose steps

This is when the physician steps the dose up, usually every four weeks. Nausea often returns for a few days at each step and fades as the body adjusts to the new level. The meal habits from month 1 carry over; the new item in months 2 and 3 is constipation, which becomes more common as the dose rises and food volume drops.

What helps in months 2 and 3:

• Fiber, every day. Vegetables, fruit with the skin, oats, beans, or a fiber supplement. Lower food volume means less fiber unless you add it deliberately.
• Fluids to go with it. Fiber without water makes constipation worse. Aim for steady intake through the day.
• A daily walk. Movement speeds up the gut. Twenty minutes after a meal is enough to make a difference for most people.
• Keep protein at every meal. Appetite is lowest at this stage, and this is when people accidentally under-eat protein.

If a step brings back nausea that does not settle within two weeks, tell the physician. The dose does not have to go up on a fixed calendar. A physician can hold the current level for another month and step up when you are ready, and that is a routine adjustment rather than a setback. At Pepvio the schedule is set by the physician and can be slowed at any point by messaging the care team.

months 4 to 6: side effects settle, weight loss is fastest

By month 4 most people are on or near their maintenance dose, and the digestive side effects have usually faded to occasional. What can appear in this stretch comes from the weight loss itself.

Fatigue and feeling cold. Eating a lot less means less energy coming in, and a lighter body loses heat faster. Both are common with rapid weight loss on any method. Regular meals with protein, adequate sleep, and enough total food (this is the stage where some people eat too little) handle most of it. Fatigue that is severe or does not improve is worth a message to the physician.

Hair shedding. Some people notice more hair in the brush from about month 3 to 6. This is telogen effluvium, a temporary shedding that follows any rapid weight loss, illness, or major stress: a larger share of hairs than usual shift into the resting phase at once and fall out two to three months later. The labels list it. Hair loss was reported by 3 percent of people on semaglutide in the weight-loss trials against 1 percent on placebo, and the label notes it was associated with the weight reduction itself; on tirzepatide it was 4 to 5 percent against 1 percent, and more common in women than men.^[4][5] It regrows once weight stabilizes, usually over several months. What helps is the same protein habit from month 1, since hair is built from it, and asking the physician to check ferritin (stored iron) if shedding is heavy, because low iron is the most common thing that prolongs it.

the long term

The approval trials ran 68 weeks for semaglutide and 72 weeks for tirzepatide.^[1][2] For semaglutide there is longer data: the SELECT trial followed 17,604 adults with overweight or obesity and existing cardiovascular disease for a mean of about 40 months, and found fewer major cardiovascular events on semaglutide than on placebo. Over that stretch, adverse events led to stopping the medication in 16.6 percent of the semaglutide group against 8.2 percent on placebo.^[3]

Two less common events are worth knowing about because they are linked to the weight loss and the medication together:

• Gallstones. Losing weight quickly by any method raises the chance of gallstones. In the semaglutide weight-loss trials, gallstones were reported by 1.6 percent of people on the medication against 0.7 percent on placebo; on tirzepatide, gallbladder inflammation was reported by 0.7 percent against 0.2 percent.^[4][5] The symptom is pain in the upper right abdomen, often after a fatty meal.
• Pancreatitis. Rare. In the semaglutide weight-loss trials, confirmed acute pancreatitis occurred in 4 people on the medication, about 0.2 cases per 100 patient-years, and 1 on placebo.^[4] The symptom is severe, steady pain in the upper abdomen that may go through to the back.

Both are in the same-day-call list below because they are treatable and the sooner they are looked at the simpler that is.

side effects that need a call the same day

Most of this article is the ordinary adjustment period. These are the exceptions. Message the care team or contact your physician the same day for any of them, and go to urgent care or an emergency room if the symptom is severe:

• Severe or persistent abdominal pain, especially steady pain in the upper abdomen, with or without vomiting, or pain in the upper right side after eating. These are the signs of pancreatitis and gallbladder trouble described above.
• Vomiting that will not stop, or vomiting that keeps you from holding down fluids for more than a day.
• Signs of dehydration: very dark urine, dizziness on standing, a dry mouth, or not urinating for many hours. Ongoing vomiting or diarrhea can get here faster than people expect, and dehydration can strain the kidneys.
• Constipation past a week with no bowel movement despite fiber, fluids, and walking, or constipation with abdominal swelling and pain.
• Allergic reaction: rash, hives, swelling of the face, lips, or throat, or trouble breathing. Swelling of the throat or trouble breathing is an emergency.

One exclusion to know about before you start. The labels for semaglutide and tirzepatide state that they should not be used by anyone with a personal or family history of medullary thyroid carcinoma, or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), because medications in this class caused thyroid C-cell tumors in rodent studies.^[4][5] Whether that applies to humans is unknown, so the labels rule these groups out as a precaution. The Pepvio intake asks about it, and a physician will not prescribe to anyone in those groups.

how a physician manages this at Pepvio

The dose schedule is set by a licensed U.S. physician after an online visit that takes about 2 minutes, and the medication is made by a licensed U.S. compounding pharmacy with your name on the label. You start on the lowest dose. The physician steps it up over the following months, and holds a level longer whenever the side effects call for it.

Pepvio's Price Lock means the price you sign up at stays the same at every dose and at every renewal. Slowing the escalation, or staying at a lower dose that is working for you, never changes what you pay, so the dose decision is made on how you feel and nothing else. If nausea returns at a step, if constipation is not responding to the steps above, or if you are unsure whether something needs attention, you message the care team from your account and the physician adjusts from there.

The GLP-1 protocol page has the current details on both medications, and the online visit below is where it starts.

---